{"resourceType": "EvidenceVariable", "meta": {"versionId": "2", "lastUpdated": "2023-11-28T11:03:54.347Z", "profile": ["https://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"]}, "title": "GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo", "useContext": [{"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "GroupAssignment", "display": "GroupAssignment"}]}}], "status": "active", "url": "https://fevir.net/resources/EvidenceVariable/179689", "id": "179689", "identifier": [{"type": {"text": "FEvIR Object Identifier"}, "system": "https://fevir.net", "value": "179689", "assigner": {"display": "Computable Publishing LLC"}}], "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Brian S. Alper"}], "relatedArtifact": [{"type": "cite-as", "citation": "GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179689. Revised 2023-11-28. Available at: https://fevir.net/resources/EvidenceVariable/179689. Computable resource at: https://fevir.net/resources/EvidenceVariable/179689."}], "handling": "polychotomous", "category": [{"name": "high dose xanomeline"}, {"name": "low dose xanomeline"}, {"name": "placebo"}]}